Association of Biotechnology Led Enterprises

News

India's first fully indigenously developed vaccine against pneumonia gets DCGI nod

With the help of Special Expert Committee (SEC) for vaccines, the drug regulator reviewed the phase I, II and III clinical trial data submitted by Serum Institute of India

Jul 16, 2020

By : Team ABLE

Glenmark reduces FabiFlu price, starts post-marketin surveillance study

Glenmark is also conducting another Phase 3 clinical trial to evaluate the efficacy of two antivirals drugs Favipiravir and Umifenovir as a combination therapy in moderate hospitalized adult COVID-19 patients in India.

Jul 14, 2020

By : Team ABLE

Biocon’s Itolizumab receives DCGI nod for its use in moderate to severe COVID-19 patients

Itolizumab will be manufactured and formulated as an intravenous injection at Biocon’s bio-manufacturing facility at Biocon Park, Bengaluru.

Jul 13, 2020

By : Team ABLE

Bangalore's VNIR Biotech launches molecular COVID-19 test probes

These molecular probes are used to track the amplification in PCR. Their immediate application is for COVID-19 testing.

Jul 13, 2020

By : Team ABLE

Russia announces completion of world’s first COVID-19 vaccine human trials

Russia had allowed clinical trials of two forms of a potential Covid-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology.

Jul 13, 2020

By : Team ABLE